498 filings
Page 2 of 25
8-K
d9vcf4l056
30 Apr 20
Aradigm Announces Conditional Approval for the Combined Chapter 11 Plan and Disclosure Statement
12:47pm
8-K
tm6ckd
13 Apr 20
Other Events
1:01pm
8-K
2daqbfu 5ocqn
3 Apr 20
Other Events
4:19pm
8-K
dkz mikrp71d
9 Mar 20
Entry into a Material Definitive Agreement
4:05pm
8-K
d7foaae3zrpyax50ok
21 Feb 20
Entry into a Material Definitive Agreement
8:30am
8-K
eijxocf0d9o
31 Oct 19
Aradigm Announces Withdrawal of European Marketing Authorization Application (MAA) for Linhaliq
12:00am
RW
g85xs0k
22 Oct 19
Registration withdrawal request
4:09pm
8-K
8d803i
21 Oct 19
Aradigm Receives Feedback Following an Oral Explanation with the European Medicines Agency
5:28pm
8-K
dja ahatww27cmeu
10 Jun 19
Entry into a Material Definitive Agreement
4:07pm
8-K
q9p1c98irb08qkyxmc
23 Apr 19
Other Events
4:04pm
8-K
hsio gpmj
22 Feb 19
Other Events
12:00am
8-K
5wlz9kxy 7s4ajcajb3
19 Feb 19
Aradigm Announces Plans for Reorganization under Chapter 11 of the U.S. Bankruptcy Code
12:00am
8-K
v4j74vjrtro 94tr
29 Jan 19
Departure of Directors or Certain Officers
5:01pm
8-K
23xydwgn5a2i3
14 Jan 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:24pm
8-K
4snx bczlu9na
10 Jan 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:23pm
8-K
5i5pkn02zdk4n1
8 Jan 19
Entry into a Material Definitive Agreement
5:01pm
RW
zae1rc8uky 1209km5s
28 Nov 18
Registration withdrawal request
1:35pm
8-K
ddmpfc
15 Nov 18
Aradigm Announces Third Quarter 2018 Financial Results
1:03pm